-
Peloton Shares Fall On Slowing Revenue, Growing Cash Burn
Thursday, February 6, 2020 - 12:16pm | 477Exercise equipment maker Peloton Interactive Inc (NASDAQ: PTON) reported a better-than-expected second-quarter loss Wednesday, but fell 10% after showing a "classic example" of two concerning metrics in its quarterly report, Sarat Sethi, managing partner at Douglas C. Lane, said Thursday...
-
Aimmune Analyst Says Palforzia Launch Funding Secured With Nestle's $200M Investment
Thursday, February 6, 2020 - 11:50am | 441Aimmune Therapeutics Inc (NASDAQ: AIMT) recently received FDA approval for its peanut allergy drug Palforzia. The Aimmune Analyst Baird analyst Brian Skorney maintained an Outperform rating on Aimmune with a $64 price target. The Aimmune Thesis With NESTLE S A/S ADR (OTC: NSRGY)...
-
Aimmune Analysts Bullish On Strong Uptake Of Peanut Allergy Drug Palforzia
Monday, February 3, 2020 - 12:47pm | 589Aimmune Therapeutics Inc (NASDAQ: AIMT) announced late Friday that it received FDA approval for Palforzia, its oral immunotherapy to treat peanut allergy. The Aimmune Analysts Baird analyst Brian Skorney maintained an Outperform rating and $64 price target for Aimmune shares. RBC Capital...
-
Street Stays Bullish On Stitch Fix, New 'Direct Buy' Features
Tuesday, December 10, 2019 - 1:40pm | 539Stitch Fix Inc (NASDAQ: SFIX) shares are surging after reporting a first-quarter earnings and sales beat. Stitch Fix earnings came in flat, beating estimates by 6 cents per share. The company reported quarterly sales of $444.8 million, which beat the analyst consensus estimate of $441 million. This...
-
CrowdStrike Delivers Another Quarterly Beat With Improvement In Key Parameters
Friday, December 6, 2019 - 12:33pm | 270Although CrowdStrike Holdings Inc (NASDAQ: CRWD) delivered another strong quarter with improvements in key matrices, the stock valuation is high relative to peers, according to Baird. The Analyst Baird’s Jonathan Ruykhaver maintained a Neutral rating for CrowdStrike, with a price target of $...
-
Zoom Video Sells Off After Q3 Earnings Print
Friday, December 6, 2019 - 12:04pm | 586Zoom Video Communications Inc. (NASDAQ: ZM) lost a bit of the zoom in its growth trajectory in the third quarter, spooking investors. Sell-side analysts said the company's communications story remains strong, though the stock price may already reflect it. The Analysts Morgan Stanley's Meta...
-
Wall Street Weighs In On Workday's Q3 Earnings
Wednesday, December 4, 2019 - 5:26pm | 658Workday Inc (NASDAQ: WDAY) shares dropped 4.8% on Wednesday after the company reported third-quarter earnings and revenue beats and raised its full-year subscription revenue guidance. Workday reported $798.5 million in total revenue, up 28% from a year ago and slightly ahead of consensus analyst...
-
Sell-Side Still Optimistic On Zscaler After Q1 Earnings Results
Wednesday, December 4, 2019 - 11:46am | 528Analysts remained upbeat on cloud security company Zscaler Inc. (NASDAQ: ZS) after strong first-quarter results, even as investors appeared more skeptical sending the stock down, likely on mixed second-quarter guidance. Zscaler beat Street expectations on revenue, billings, and non-GAAP EPS in the...
-
Wall Street Is As Bullish As Ever On Salesforce
Wednesday, December 4, 2019 - 11:16am | 676Salesforce.com, Inc. (NYSE: CRM) shares dipped 3.5% after the company reported third-quarter revenue and earnings ahead of consensus analyst expectations on Tuesday. Revenue performance obligation (RPO) growth guidance of 21% for the fourth quarter came up short of consensus expectations of 23%....
-
Biogen's Alzheimer's Drug 'Falls Far Short Of Compelling Argument For Approval,' Baird Says In Downgrade
Monday, December 2, 2019 - 2:55pm | 413Biogen Inc (NASDAQ: BIIB) shares gained more than 25% earlier this year when the company said it planned a regulatory filing for its Alzheimer's drug aducanumab following a new data analysis. Ahead of the Dec. 5 presentation of aducanumab data at the Clinical Trials on Alzheimer'...
-
'Their Model Continues To Thrive': TJX Analysts React To Q3 Earnings Beat
Wednesday, November 20, 2019 - 6:12pm | 741TJX Companies Inc (NYSE: TJX) shares are falling one day after the retailer reported a third-quarter earnings beat. Morgan Stanley Analyst Kimberly Greenberger said she sees off-price share gains from department stores, specialty and discount retailers continuing. “Off-price...
-
2 Analysts React To Urban Outfitters' Sales Miss, Stock Drop
Wednesday, November 20, 2019 - 4:14pm | 383Urban Outfitters, Inc. (NASDAQ: URBN) shares are in free-fall mode after reporting a third-quarter earnings miss on Tuesday. Encouraged By Improved Results Baird analyst Mark Altschwager said he was encouraged by Urban Outfitters improved results fueled by a resurgence at Anthropologie and strength...
-
The Street Debates If Now Is The Time To Shop For Kohl's Stock
Wednesday, November 20, 2019 - 12:16pm | 616Kohl's Corporation (NYSE: KSS) disappointed investors Tuesday with an EPS miss in its third-quarter report, along with a downward revision in its full-year outlook. Here is a summary of how some of the Street's top analysts reacted to the print. The Analysts Wedbush analyst Jen Redding...
-
Home Depot Fix Up Is Coming: Analysts Not As Bearish As Investors After Sales Miss
Wednesday, November 20, 2019 - 11:38am | 623Home Depot Inc (NYSE: HD) shares were dropping again on Wednesday, continuing a sell-off that followed a revenue miss, disappointing same-store sales and a downward revision to guidance. But several sell-side analysts said underlying trends point to a sales rebound, adding the company should see a...
-
Baird's Positive Long-Term View On Shake Shack Tempered By Near-Term Concerns
Tuesday, November 19, 2019 - 12:26pm | 344Shake Shack Inc (NYSE: SHAK) is among the few companies in the space that can deliver "well above-average" revenue and earnings growth over the longer term, but this doesn't mean investors should be buyers of the stock right now, according to Baird. The Analyst Baird analyst David...